by Corporate Image | Jul 29, 2021 | Branstetter Stranch & Jennings, Sullivan Baby Doe
Settlement Announcement Shared By BS&J And Regional DAGs KINGSPORT, Tenn., July 29, 2021 /PRNewswire/ — A $35 million settlement agreement has been reached in the Sullivan Baby Doe suit, capping more than four years of litigation against U.S. opioid...
by Corporate Image | Feb 24, 2020 | Branstetter Stranch & Jennings
Lawsuit cleared to move forward in litigation KNOXVILLE, Tenn. — On Monday, Feb. 24, it was announced that the Tennessee Supreme Court refused to hear an appeal from multiple opioid producer defendants that would have provided another opportunity for those companies...
by Corporate Image | Dec 20, 2019 | Branstetter Stranch & Jennings
BRISTOL, Tenn. — A cache of reports compiled by expert witnesses in the upcoming May 2020 Sullivan Baby Doe trial will be released, following a push by regional district attorneys general (DAGs) to make the documents public. The documents, previously filed under seal,...
by Corporate Image | Oct 30, 2019 | Branstetter Stranch & Jennings
KINGSPORT, Tenn. — The Sullivan Baby Doe lawsuit is headed to trial. At a hearing today in Sullivan County Circuit Court, Chancellor E.G. Moody scheduled a trial date of Monday, May 18, 2020, for the region’s central opioid suit and set the venue in Bristol,...
by Corporate Image | Sep 16, 2019 | Branstetter Stranch & Jennings
National agreement would settle complaints brought against Purdue by cities/counties, but leaves other defendants to be pursued in court JACKSBORO, Tenn. — A proposed multi-billion dollar settlement and bankruptcy filing by Purdue Pharma in the national opioid...
by Corporate Image | Sep 16, 2019 | Branstetter Stranch & Jennings
National agreement would settle complaints brought against Purdue by cities/counties, but leaves other defendants to be pursued in court CROSSVILLE, Tenn. — A proposed multi-billion dollar settlement and bankruptcy filing by Purdue Pharma in the national opioid...
